Short-TermMedium-TermLong-TermSignals

SELLAS Life Sciences [SLS]

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Last Updated 23 Jun 2026 @ 13:33 (Exchange is open)
Last: $9.12 6.86%
0.61 (↑)
GaG Algo Score™
v1.0
Short
0.61 (↑)
Medium
2.50 (↑)
Long
1.94 (↑)
BUY
59.18%
return 32.32%
SELL
64.00%
return -26.16%

Stats

Today's Volume 4.75M
Average Volume 7.50M
Market Cap 1.22B
EPS $-0.0487 (Q1 | 2026-05-12)
Next earnings date ($-0.0500) 2026-08-11
Last Dividend $0.420 (2010-12-09)
P/E -39.63 (Sector) 26.21 (Industry) 17.28
ATR14 $0.669 (8.31%)
Possible DaySwing $7.72 - $8.38 (8.67%)

Support and Resistance Levels

Line

Pivot Data

Pivot Statistics
Metric Average Median Std Dev
Gain % 50.50% 30.17% 51.20%
Loss % -18.88% -18.88% 6.11%
Duration 16.0d 12d 11.5d
Total Pivots Found 6
Gain/Loss Legs 5 (3 Gain / 2 Loss)
Last Pivot Top @ $8.05 on 2026-06-18
Change since Last Pivot $0.00 (0.00%)
Next Pivot Prediction Last: $9.12
Predicted Next Type Bottom
Predicted Price (Avg) $6.53
Predicted Price (Median) $6.53
Predicted Price Range (~68%) $6.04 - $7.02
Change to Avg Target $-2.58 (-28.36%)
Predicted Date (Avg) 2026-07-04
Predicted Date Range (~68%) 2026-06-22 - 2026-07-15
Basis Based on 2 historical losses (Avg: -18.88%, Median: -18.88%, StdDev of Abs: 6.11%) and duration (Avg: 16.0 days, StdDev: 11.5 days)
Note Ranges assume ~normal distribution & historical patterns repeat. Use with caution.

Significant gain for SELLAS Life Sciences, up 3.74%.

SELLAS Life Sciences (SLS) stock price showed an impressive upswing on Thursday after the stock rose $0.290 (3.74%) from the previous session on very high volume. The stock moderately outperformed the market today, rising faster than the NASDAQ's 1.91% gain. With 14.75M shares traded, volume yesterday reached $118.72M. This was 10.07M shares more than the prior day. Compared to the 10-day average of 5.98M shares, volume was more than the average.

SELLAS Life Sciences signals

There is no conclusive signals given from RSI. The price is above both the short- and long-term averages, and the short-term average is above the long-term average, confirming an established up-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (16.7%), medium- (16.7%), and long-term (16.7%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.

SELLAS Life Sciences Support & Resistance Levels

The stock is approaching the closest resistance level at $8.33. approximately $0.280 (3.48%) away. Approaching it. Breaking above this level could signal further upside where next resistance level will be found at $8.97. On a fall back there will be support at $6.53 The dis das resistance s16.53 -

SELLAS Life Sciences Evaluation

  • Short score: 0.61
  • Medium score: 2.50
  • Long score: 1.94